APO RESEARCH · REPORT
Medical Polymers
The medical polymers market comprises resins and fibers, elastomers and biodegradable plastics that are used in various healthcare applications such as equipment and devices, packaging and tissue engineering. Polyvinyl chloride, polypropylene, polystyrene and polyethylene are the commonly used fibers and resins in the medical industry.
Product & engineering
Understand the product.
The medical polymers market comprises resins and fibers, elastomers and biodegradable plastics that are used in various healthcare applications such as equipment and devices, packaging and tissue engineering. Polyvinyl chloride, polypropylene, polystyrene and polyethylene are the commonly used fibers and resins in the medical industry.
Selected research
Industry Growth & Trends
Global Medical Polymers Industry Growth and Trends Forecast to 2032
Market perspective
The medical polymers market comprises resins and fibers, elastomers and biodegradable plastics that are used in various healthcare applications such as equipment and devices, packaging and tissue engineering. Polyvinyl chloride, polypropylene, polystyrene and polyethylene are the commonly used fibers and resins in the medical industry.
The major players in global Medical Polymers market include BASF SE, Bayer, Celanese, DSM, Du Pont, etc. The top 5 players occupy about 20% shares of the global market. Europe and North America are main markets, they occupy over 60% of the global market. Medical Resins and Fibers is the main type, with a share about 80%. Medical Packaging is the main application, which holds a share about 50%.
Report Scope
Read the full market overview
This report provides a structured, data-driven view of the global Medical Polymers market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Medical Polymers market size, estimates, and forecasts are presented in terms of sales volume (kt) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Medical Polymers market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Medical Polymers.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading manufacturers in the global Medical Polymers market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Medical Polymers Market by Company
BASF SE
Bayer
Celanese
DSM
DuPont
Solvay
Eastman Chemical
Evonik
HEXPOL
Exxon Mobil
Formosa Plastics
INEOS
Victrex
Colorite Compounds
Raumedic
Kraton
Tianjin Plastics
Shanghai New Shanghua
Medical Polymers Segment by Type
Medical Resins and Fibers
Medical Elastomers
Biodegradable Plastics
Other
Medical Polymers Segment by Application
Medical Devices and Equipment
Medical Packaging
Others (Including Tissue Engineering and Cardio Stents)
Medical Polymers Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Medical Polymers market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Medical Polymers and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Medical Polymers.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Medical Polymers manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Medical Polymers in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Medical Resins and Fibers
- Medical Elastomers
- Biodegradable Plastics
- Other
Applications
- Medical Devices and Equipment
- Medical Packaging
- Others (Including Tissue Engineering and Cardio Stents)
Companies covered
- BASF SE
- Bayer
- Celanese
- DSM
- DuPont
- Solvay
- Eastman Chemical
- Evonik
- HEXPOL
- Exxon Mobil
- Formosa Plastics
- INEOS
- Victrex
- Colorite Compounds
- Raumedic
- Kraton
- Tianjin Plastics
- Shanghai New Shanghua
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Medical Polymers Market Size Estimates and Forecasts (2021-2032)
- 1.2.2 Global Medical Polymers Sales Estimates and Forecasts (2021-2032)
- 1.3 Medical Polymers Market by Type
- 1.3.1 Medical Resins and Fibers
- 1.3.2 Medical Elastomers
- 1.3.3 Biodegradable Plastics
- 1.3.4 Other
- 1.4 Global Medical Polymers Market Size by Type
- 1.4.1 Global Medical Polymers Market Size Overview by Type (2021-2032)
- 1.4.2 Global Medical Polymers Historic Market Size Review by Type (2021-2026)
- 1.4.3 Global Medical Polymers Forecasted Market Size by Type (2027-2032)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America Medical Polymers Sales Breakdown by Type (2021-2026)
- 1.5.2 Europe Medical Polymers Sales Breakdown by Type (2021-2026)
- 1.5.3 Asia-Pacific Medical Polymers Sales Breakdown by Type (2021-2026)
- 1.5.4 South America Medical Polymers Sales Breakdown by Type (2021-2026)
- 1.5.5 Middle East and Africa Medical Polymers Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
- 2.1 Medical Polymers Industry Trends
- 2.2 Medical Polymers Industry Drivers
- 2.3 Medical Polymers Industry Opportunities and Challenges
- 2.4 Medical Polymers Industry Restraints
3 Market Competitive Landscape by Company
- 3.1 Global Top Players by Medical Polymers Revenue (2021-2026)
- 3.2 Global Top Players by Medical Polymers Sales (2021-2026)
- 3.3 Global Top Players by Medical Polymers Price (2021-2026)
- 3.4 Global Medical Polymers Industry Company Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Medical Polymers Major Company Production Sites & Headquarters
- 3.6 Global Medical Polymers Company, Product Type & Application
- 3.7 Global Medical Polymers Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Medical Polymers Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Medical Polymers Players Market Share by Revenue in 2025
- 3.8.3 2025 Medical Polymers Tier 1, Tier 2, and Tier 3
4 Medical Polymers Regional Status and Outlook
- 4.1 Global Medical Polymers Market Size and CAGR by Region: 2021 VS 2025 VS 2032
- 4.2 Global Medical Polymers Historic Market Size by Region
- 4.2.1 Global Medical Polymers Sales in Volume by Region (2021-2026)
- 4.2.2 Global Medical Polymers Sales in Value by Region (2021-2026)
- 4.2.3 Global Medical Polymers Sales (Volume & Value), Price and Gross Margin (2021-2026)
- 4.3 Global Medical Polymers Forecasted Market Size by Region
- 4.3.1 Global Medical Polymers Sales in Volume by Region (2027-2032)
- 4.3.2 Global Medical Polymers Sales in Value by Region (2027-2032)
- 4.3.3 Global Medical Polymers Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Medical Polymers by Application
- 5.1 Medical Polymers Market by Application
- 5.1.1 Medical Devices and Equipment
- 5.1.2 Medical Packaging
- 5.1.3 Others (Including Tissue Engineering and Cardio Stents)
- 5.2 Global Medical Polymers Market Size by Application
- 5.2.1 Global Medical Polymers Market Size Overview by Application (2021-2032)
- 5.2.2 Global Medical Polymers Historic Market Size Review by Application (2021-2026)
- 5.2.3 Global Medical Polymers Forecasted Market Size by Application (2027-2032)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America Medical Polymers Sales Breakdown by Application (2021-2026)
- 5.3.2 Europe Medical Polymers Sales Breakdown by Application (2021-2026)
- 5.3.3 Asia-Pacific Medical Polymers Sales Breakdown by Application (2021-2026)
- 5.3.4 South America Medical Polymers Sales Breakdown by Application (2021-2026)
- 5.3.5 Middle East and Africa Medical Polymers Sales Breakdown by Application (2021-2026)
6 Company Profiles
- 6.1 BASF SE
- 6.1.1 BASF SE Company Information
- 6.1.2 BASF SE Business Overview
- 6.1.3 BASF SE Medical Polymers Sales, Revenue and Gross Margin (2021-2026)
- 6.1.4 BASF SE Medical Polymers Product Portfolio
- 6.1.5 BASF SE Recent Developments
- 6.2 Bayer
- 6.2.1 Bayer Company Information
- 6.2.2 Bayer Business Overview
- 6.2.3 Bayer Medical Polymers Sales, Revenue and Gross Margin (2021-2026)
- 6.2.4 Bayer Medical Polymers Product Portfolio
- 6.2.5 Bayer Recent Developments
- 6.3 Celanese
- 6.3.1 Celanese Company Information
- 6.3.2 Celanese Business Overview
- 6.3.3 Celanese Medical Polymers Sales, Revenue and Gross Margin (2021-2026)
- 6.3.4 Celanese Medical Polymers Product Portfolio
- 6.3.5 Celanese Recent Developments
- 6.4 DSM
- 6.4.1 DSM Company Information
- 6.4.2 DSM Business Overview
- 6.4.3 DSM Medical Polymers Sales, Revenue and Gross Margin (2021-2026)
- 6.4.4 DSM Medical Polymers Product Portfolio
- 6.4.5 DSM Recent Developments
- 6.5 DuPont
- 6.5.1 DuPont Company Information
- 6.5.2 DuPont Business Overview
- 6.5.3 DuPont Medical Polymers Sales, Revenue and Gross Margin (2021-2026)
- 6.5.4 DuPont Medical Polymers Product Portfolio
- 6.5.5 DuPont Recent Developments
- 6.6 Solvay
- 6.6.1 Solvay Company Information
- 6.6.2 Solvay Business Overview
- 6.6.3 Solvay Medical Polymers Sales, Revenue and Gross Margin (2021-2026)
- 6.6.4 Solvay Medical Polymers Product Portfolio
- 6.6.5 Solvay Recent Developments
- 6.7 Eastman Chemical
- 6.7.1 Eastman Chemical Company Information
- 6.7.2 Eastman Chemical Business Overview
- 6.7.3 Eastman Chemical Medical Polymers Sales, Revenue and Gross Margin (2021-2026)
- 6.7.4 Eastman Chemical Medical Polymers Product Portfolio
- 6.7.5 Eastman Chemical Recent Developments
- 6.8 Evonik
- 6.8.1 Evonik Company Information
- 6.8.2 Evonik Business Overview
- 6.8.3 Evonik Medical Polymers Sales, Revenue and Gross Margin (2021-2026)
- 6.8.4 Evonik Medical Polymers Product Portfolio
- 6.8.5 Evonik Recent Developments
- 6.9 HEXPOL
- 6.9.1 HEXPOL Company Information
- 6.9.2 HEXPOL Business Overview
- 6.9.3 HEXPOL Medical Polymers Sales, Revenue and Gross Margin (2021-2026)
- 6.9.4 HEXPOL Medical Polymers Product Portfolio
- 6.9.5 HEXPOL Recent Developments
- 6.10 Exxon Mobil
- 6.10.1 Exxon Mobil Company Information
- 6.10.2 Exxon Mobil Business Overview
- 6.10.3 Exxon Mobil Medical Polymers Sales, Revenue and Gross Margin (2021-2026)
- 6.10.4 Exxon Mobil Medical Polymers Product Portfolio
- 6.10.5 Exxon Mobil Recent Developments
- 6.11 Formosa Plastics
- 6.11.1 Formosa Plastics Company Information
- 6.11.2 Formosa Plastics Business Overview
- 6.11.3 Formosa Plastics Medical Polymers Sales, Revenue and Gross Margin (2021-2026)
- 6.11.4 Formosa Plastics Medical Polymers Product Portfolio
- 6.11.5 Formosa Plastics Recent Developments
- 6.12 INEOS
- 6.12.1 INEOS Company Information
- 6.12.2 INEOS Business Overview
- 6.12.3 INEOS Medical Polymers Sales, Revenue and Gross Margin (2021-2026)
- 6.12.4 INEOS Medical Polymers Product Portfolio
- 6.12.5 INEOS Recent Developments
- 6.13 Victrex
- 6.13.1 Victrex Company Information
- 6.13.2 Victrex Business Overview
- 6.13.3 Victrex Medical Polymers Sales, Revenue and Gross Margin (2021-2026)
- 6.13.4 Victrex Medical Polymers Product Portfolio
- 6.13.5 Victrex Recent Developments
- 6.14 Colorite Compounds
- 6.14.1 Colorite Compounds Company Information
- 6.14.2 Colorite Compounds Business Overview
- 6.14.3 Colorite Compounds Medical Polymers Sales, Revenue and Gross Margin (2021-2026)
- 6.14.4 Colorite Compounds Medical Polymers Product Portfolio
- 6.14.5 Colorite Compounds Recent Developments
- 6.15 Raumedic
- 6.15.1 Raumedic Company Information
- 6.15.2 Raumedic Business Overview
- 6.15.3 Raumedic Medical Polymers Sales, Revenue and Gross Margin (2021-2026)
- 6.15.4 Raumedic Medical Polymers Product Portfolio
- 6.15.5 Raumedic Recent Developments
- 6.16 Kraton
- 6.16.1 Kraton Company Information
- 6.16.2 Kraton Business Overview
- 6.16.3 Kraton Medical Polymers Sales, Revenue and Gross Margin (2021-2026)
- 6.16.4 Kraton Medical Polymers Product Portfolio
- 6.16.5 Kraton Recent Developments
- 6.17 Tianjin Plastics
- 6.17.1 Tianjin Plastics Company Information
- 6.17.2 Tianjin Plastics Business Overview
- 6.17.3 Tianjin Plastics Medical Polymers Sales, Revenue and Gross Margin (2021-2026)
- 6.17.4 Tianjin Plastics Medical Polymers Product Portfolio
- 6.17.5 Tianjin Plastics Recent Developments
- 6.18 Shanghai New Shanghua
- 6.18.1 Shanghai New Shanghua Company Information
- 6.18.2 Shanghai New Shanghua Business Overview
- 6.18.3 Shanghai New Shanghua Medical Polymers Sales, Revenue and Gross Margin (2021-2026)
- 6.18.4 Shanghai New Shanghua Medical Polymers Product Portfolio
- 6.18.5 Shanghai New Shanghua Recent Developments
7 North America by Country
- 7.1 North America Medical Polymers Sales by Country
- 7.1.1 North America Medical Polymers Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.1.2 North America Medical Polymers Sales by Country (2021-2026)
- 7.1.3 North America Medical Polymers Sales Forecast by Country (2027-2032)
- 7.2 North America Medical Polymers Market Size by Country
- 7.2.1 North America Medical Polymers Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2.2 North America Medical Polymers Market Size by Country (2021-2026)
- 7.2.3 North America Medical Polymers Market Size Forecast by Country (2027-2032)
8 Europe by Country
- 8.1 Europe Medical Polymers Sales by Country
- 8.1.1 Europe Medical Polymers Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.1.2 Europe Medical Polymers Sales by Country (2021-2026)
- 8.1.3 Europe Medical Polymers Sales Forecast by Country (2027-2032)
- 8.2 Europe Medical Polymers Market Size by Country
- 8.2.1 Europe Medical Polymers Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2.2 Europe Medical Polymers Market Size by Country (2021-2026)
- 8.2.3 Europe Medical Polymers Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
- 9.1 Asia-Pacific Medical Polymers Sales by Country
- 9.1.1 Asia-Pacific Medical Polymers Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.1.2 Asia-Pacific Medical Polymers Sales by Country (2021-2026)
- 9.1.3 Asia-Pacific Medical Polymers Sales Forecast by Country (2027-2032)
- 9.2 Asia-Pacific Medical Polymers Market Size by Country
- 9.2.1 Asia-Pacific Medical Polymers Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2.2 Asia-Pacific Medical Polymers Market Size by Country (2021-2026)
- 9.2.3 Asia-Pacific Medical Polymers Market Size Forecast by Country (2027-2032)
10 South America by Country
- 10.1 South America Medical Polymers Sales by Country
- 10.1.1 South America Medical Polymers Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.1.2 South America Medical Polymers Sales by Country (2021-2026)
- 10.1.3 South America Medical Polymers Sales Forecast by Country (2027-2032)
- 10.2 South America Medical Polymers Market Size by Country
- 10.2.1 South America Medical Polymers Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2.2 South America Medical Polymers Market Size by Country (2021-2026)
- 10.2.3 South America Medical Polymers Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
- 11.1 Middle East and Africa Medical Polymers Sales by Country
- 11.1.1 Middle East and Africa Medical Polymers Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.1.2 Middle East and Africa Medical Polymers Sales by Country (2021-2026)
- 11.1.3 Middle East and Africa Medical Polymers Sales Forecast by Country (2027-2032)
- 11.2 Middle East and Africa Medical Polymers Market Size by Country
- 11.2.1 Middle East and Africa Medical Polymers Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2.2 Middle East and Africa Medical Polymers Market Size by Country (2021-2026)
- 11.2.3 Middle East and Africa Medical Polymers Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
- 12.1 Medical Polymers Value Chain Analysis
- 12.1.1 Medical Polymers Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 Medical Polymers Production Mode & Process
- 12.2 Medical Polymers Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 Medical Polymers Distributors
- 12.2.3 Medical Polymers Customers
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst